Citadel Advisors - ZOMEDICA PHARMACEUTICALS COR ownership

ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 29 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ZOMEDICA PHARMACEUTICALS COR
ValueSharesWeighting
Q3 2020$125,000
-2.3%
1,131,264
+111.1%
0.00%
Q2 2020$128,000
+4166.7%
536,012
+3140.3%
0.00%
Q1 2020$3,000
-86.4%
16,542
-74.8%
0.00%
Q4 2019$22,000
+46.7%
65,650
+67.7%
0.00%
Q3 2019$15,000
-16.7%
39,141
-22.3%
0.00%
Q1 2019$18,000
-14.3%
50,343
+188.3%
0.00%
Q4 2018$21,000
-66.1%
17,460
-47.7%
0.00%
Q3 2018$62,000
+19.2%
33,410
+28.1%
0.00%
Q4 2017$52,00026,0900.00%
Other shareholders
ZOMEDICA PHARMACEUTICALS COR shareholders Q2 2020
NameSharesValueWeighting ↓
Cambridge Investment Research Advisors, Inc. 12,254,080$1,349,0000.01%
SABBY MANAGEMENT, LLC 470,548$52,0000.01%
jvl associates llc 58,500$6,0000.01%
WINTON GROUP Ltd 717,882$79,0000.00%
REILLY FINANCIAL ADVISORS, LLC 172,031$19,0000.00%
THOROUGHBRED FINANCIAL SERVICES, LLC 21,000$2,0000.00%
RETIREMENT INCOME SOLUTIONS, INC 32,060$3,000,0000.00%
JANE STREET GROUP, LLC 223,538$25,0000.00%
Sequoia Financial Advisors, LLC 15,000$2,0000.00%
UBS Group AG 105,639$12,0000.00%
View complete list of ZOMEDICA PHARMACEUTICALS COR shareholders